Telnov A - Search Results

1

Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique.

Bastard M, Molfino L, Mutaquiha C, Galindo MA, Zindoga P, Vaz D, Mahinça I, DuCros P, Rusch B, Telnov A. Bastard M, et al. Among authors: telnov a. Clin Infect Dis. 2019 Oct 30;69(10):1809-1811. doi: 10.1093/cid/ciz196. Clin Infect Dis. 2019. PMID: 30901021

2

Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.

Bonnet M, Bastard M, du Cros P, Khamraev A, Kimenye K, Khurkhumal S, Hayrapetyan A, Themba D, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F. Bonnet M, et al. Among authors: telnov a. Int J Tuberc Lung Dis. 2016 Feb;20(2):177-86. doi: 10.5588/ijtld.15.0962. Int J Tuberc Lung Dis. 2016. PMID: 26792469

3

What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?

Bastard M, Sanchez-Padilla E, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Fadul Perez S, Telnov A, Hewison C, Varaine F, Bonnet M. Bastard M, et al. Among authors: telnov a. Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1060-1067. doi: 10.5588/ijtld.18.0649. Int J Tuberc Lung Dis. 2019. PMID: 31627770

4

Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?

Bastard M, Bonnet M, du Cros P, Khamraev AK, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F. Bastard M, et al. Among authors: telnov a. Am J Respir Crit Care Med. 2015 Feb 1;191(3):355-8. doi: 10.1164/rccm.201407-1302LE. Am J Respir Crit Care Med. 2015. PMID: 25635495 No abstract available.

5

Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

Bastard M, Bonnet M, du Cros P, Khamraev AK, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F. Bastard M, et al. Among authors: telnov a. Am J Respir Crit Care Med. 2015 Jul 1;192(1):117-8. doi: 10.1164/rccm.201504-0747LE. Am J Respir Crit Care Med. 2015. PMID: 26131996 No abstract available.

6

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Bastard M, Sanchez-Padilla E, du Cros P, Khamraev AK, Parpieva N, Tillyashaykov M, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Perez SF, Telnov A, Hewison C, Varaine F, Bonnet M. Bastard M, et al. Among authors: telnov a. PLoS One. 2018 Mar 8;13(3):e0193491. doi: 10.1371/journal.pone.0193491. eCollection 2018. PLoS One. 2018. PMID: 29518098 Free PMC article.

7

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin.

Coldiron ME, Gutierrez Zamudio AG, Manuel R, Luciano G, Rusch B, Ciglenecki I, Telnov A, Grais RF, Trellu LT, Molfino L. Coldiron ME, et al. Among authors: telnov a. Infect Agent Cancer. 2021 Jan 7;16(1):2. doi: 10.1186/s13027-020-00341-4. Infect Agent Cancer. 2021. PMID: 33413521 Free PMC article.

8

Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.

Huerga H, Mathabire Rucker SC, Cossa L, Bastard M, Amoros I, Manhiça I, Mbendera K, Telnov A, Szumilin E, Sanchez-Padilla E, Molfino L. Huerga H, et al. Among authors: telnov a. PLoS Med. 2019 Apr 30;16(4):e1002792. doi: 10.1371/journal.pmed.1002792. eCollection 2019 Apr. PLoS Med. 2019. PMID: 31039161 Free PMC article.

9

Successful expansion of community-based drug-resistant TB care in rural Eswatini - a retrospective cohort study.

Kerschberger B, Telnov A, Yano N, Cox H, Zabsonre I, Kabore SM, Vambe D, Ngwenya S, Rusch B, Tombo ML, Ciglenecki I. Kerschberger B, et al. Among authors: telnov a. Trop Med Int Health. 2019 Oct;24(10):1243-1258. doi: 10.1111/tmi.13299. Epub 2019 Aug 27. Trop Med Int Health. 2019. PMID: 31390108 Free PMC article.

10

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients.

Huerga H, Cossa L, Manhiça I, Bastard M, Telnov A, Molfino L, Sanchez-Padilla E. Huerga H, et al. Among authors: telnov a. Am J Trop Med Hyg. 2020 Mar;102(3):562-566. doi: 10.4269/ajtmh.19-0493. Am J Trop Med Hyg. 2020. PMID: 31971152 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters